Filter
1326
Filtered Results: 1326
Text search:
biological
agents
Featured
Recommendations
141
New Publications
317
Language
Document type
No document type
722
Guidelines
234
Studies & Reports
205
Manuals
88
Strategic & Response Plan
29
Training Material
18
Fact sheets
17
Brochures
3
Situation Updates
3
Resource Platforms
2
Infographics
2
Online Courses
2
Dashboards/Maps
1
Countries / Regions
India
81
Global
57
Kenya
39
Nigeria
31
Sierra Leone
28
Africa
26
Ethiopia
25
South Africa
24
Western and Central Europe
21
Liberia
21
Tanzania
19
Uganda
19
Latin America and the Carribbean
17
Nepal
16
Bangladesh
14
Ghana
13
Philippines
13
Rwanda
11
Syria
11
Zimbabwe
10
Congo, Democratic Republic of
10
Zambia
10
Malawi
9
USA
9
South–East Asia Region
9
West and Central Africa
8
Eastern Europe
8
Brazil
8
Namibia
8
Ukraine
7
Mozambique
7
Cambodia
7
Germany
7
Lesotho
6
Guinea
6
Myanmar / Burma
6
Albania
5
Burkina Faso
5
Tajikistan
4
East and Southern Africa
4
South Sudan
4
Senegal
3
Eastern Europe and Central Asia
3
Paraguay
3
Spain
3
Vietnam
3
Mali
3
Angola
3
Eswatini/ Swaziland
3
Timor Leste/ East Timor
2
Thailand
2
China
2
Peru
2
Haiti
2
Guinea-Bissau
2
Venezuela
2
Lebanon
2
Sri Lanka
2
Libya
2
Botswana
2
Indonesia
2
Iraq
2
Pakistan
2
North Macedonia
1
Turkey
1
Cameroon
1
Iran
1
Singapore
1
Laos
1
Estonia
1
Niger
1
Mongolia
1
Asia
1
Middle East and North Africa
1
Western Pacific Region
1
Turkmenistan
1
Denmark
1
France
1
United Kingdom
1
Portugal
1
Latvia
1
Côte d’Ivoire / Ivory Coast
1
Argentina
1
Papua New Guinea
1
Moldova
1
Russia
1
Romania
1
Palestine
1
Authors & Publishers
Publication Years
Category
Countries
423
Clinical Guidelines
143
Public Health
86
Key Resources
72
Pharmacy & Technologies
49
Women & Child Health
40
Capacity Building
22
Toolboxes
Planetary Health
92
Rapid Response
83
COVID-19
83
Mental Health
76
HIV
70
TB
69
AMR
69
Ebola
56
Pharmacy
54
NTDs
48
Specific Hazards
43
Conflict
26
Caregiver
25
NCDs
25
Global Health Education
21
Natural Hazards
16
Refugee
14
Zika
14
Disability
11
Cholera
7
Polio
6
Social Ethics
4
Health Financing Toolbox
2
South Sudan
1
This pocket guide offers basic information needed for the medical management of victims of radiation incidents in an easy-to-understand manner.
As the culminating volume in the DCP3 series, volume 9 will provide an overview of DCP3 findings and methods, a summary of messages and substantive lessons to be taken from DCP3, and a further discussion of cross-cutting and synthesizing topics across the first eight volumes. The introductory chapte...
Setting WHO directions
Injury to the skin and underlying tissues from acute exposure to
a large external dose of radiation is referred to as cutaneous
radiation injury (CRI). Acute radiation syndrome (ARS) 1 will
usually be accompanied by some skin damage; however, CRI
can ...
Successful detonation of an improvised nuclear device (IND) would be a catastrophic event, causing an unprecedented number of injuries and lives lost, as well as economic, political, and social disruption. However, an effective medical response and an infrastructure prepared to protect itself from f...
"This Code provides practical guidance on how to manage health and safety risks associated with hazardous
chemicals for persons conducting a business or undertaking who use chemicals in their workplace."
Specific Objectives
• To increase the knowledge and awareness of personnel on chemical management.
• To educate the personnel on the potential adverse health effects of chemical exposure.
• To educate the personnel on the existing laws pertaining to handling of hazardous
chemicals.
• To...
On January 14-16, 2003, the Centers for Disease Control and Prevention (CDC) held a communications roundtable in Atlanta, Georgia, to explore hospitals' challenges in communicating with internal and external audiences in communitywide emergencies involving radioactive materials. The roundtable, Hosp...
Exposure draft for comment October 2013
The use of explosive weapons, such as bombs, rockets, and mortar and
artillery shells, in cities, towns and villages and in other populated areas
has devastating humanitarian consequences. Explosive weapons act mainly
through the projection of blast and fragmentation wi...
This document is one of eight PDF documents that comprise the Guidance on Child-focused Victim
Assistance. All are available in PDF at
Third edition.
The main changes within the third edition of the JEE tool include the split of the technical area National legislation, policy, and financing into two technical areas (Legal instruments and Financing); the drop of the technical area previously titled Reporting and the move of indicat...
The strategic plan reflects shared commitments to enhance collaboration between environmental, animal (wildlife and domestic) and human health, and building new One Health workforce capacity through higher institutions of learning. The strategy also outlines interventions to be undertaken by governm...
Prepared for the Stunting Prevention and Reduction Project - The project Medical Waste Management Plan’s (MWMP) overall objective is to prevent and/or mitigate the negative effects of increased generation of medical waste on human health and the environment. The plan proposes measures to prevent t...
The main objectives of these guidelines are to:
1. contribute to the quality assurance of medicinal plant materials used as the source for herbal medicines to improve the quality, safety and efficacy of finished herbal products; 2. guide the formulation of national and/or regional GACP guideli...
1. contribute to the quality assurance of medicinal plant materials used as the source for herbal medicines to improve the quality, safety and efficacy of finished herbal products; 2. guide the formulation of national and/or regional GACP guideli...
These guidelines have been developed to provide guidance to the Ministry of Health in managing applications for registration of human pharmaceutical products in Rwanda. It was compiled by the Technical Working Group (TWG) on Medicines Evaluation and Registration (MER) of the East African Community M...
Rwanda Guidelines for variation to registered pharmaceutical products.
This report is primarily intended for the community of policymakers and researchers concerned about the rising risks of domestic, regional, and global infectious disease epidemics, and the collective failure to take the coordinated actions required to reduce such risks. These risks include the expec...
